Amphastar Pharmaceuticals
AMPH
#5863
Rank
A$1.78 B
Marketcap
A$41.88
Share price
-5.47%
Change (1 day)
5.26%
Change (1 year)

Earnings for Amphastar Pharmaceuticals (AMPH)

Earnings in 2026 (TTM): A$0.18 Billion

According to Amphastar Pharmaceuticals's latest financial reports the company's current earnings are A$0.73 Billion. In 2025 the company made an earning of A$0.22 Billion a decrease over its 2024 earnings that were of A$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Amphastar Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.18 B-15.01%
2025 A$0.22 B-32.26%
2024 A$0.32 B10.88%
2023 A$0.29 B68.4%
2022 A$0.17 B38.65%
2021 A$0.12 B1596.75%
2020 A$7.47 M-91.7%
2019 A$89.99 M-723.23%
2018 -A$14.45 Million-516.29%
2017 A$3.46 M-85.44%
2016 A$23.81 M-270.31%
2015 -A$13.99 Million-46.53%
2014 -A$26.16 Million-196.44%
2013 A$27.11 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Tonix Pharmaceuticals
TNXP
-A$0.25 Billion-226.72%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
-A$15.27 Million-107.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Marinus Pharmaceuticals
MRNS
-A$0.21 Billion-209.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-A$22.41 Million-111.73%๐Ÿ‡บ๐Ÿ‡ธ USA